Skip to main content
Clinical Trials/IRCT20100314003566N15
IRCT20100314003566N15RecruitingPhase 2

Evaluation of the effectiveness of botulinum toxin in preventing hypertrophic scarring at the site of surgical wounds on the trunk, limbs and neck

Tabriz University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 80 years (—)
Sex
All

Inclusion Criteria

  • Patients between 18 and 80 years of age with recent history of trunk, neck or extremity surgery in less than 10 days
  • Insensitivity to botulinum toxin
  • Consent to participate in the research project
  • Scar site with at least 2 cm

Exclusion Criteria

  • History of allergy to botulinum toxin
  • Pregnancy or breastfeeding
  • Recent botulinum injection within 6 months
  • History of radiotherapy and chemotherapy
  • History of wound healing disorder
  • History of recent surgery at the current site of surgery
  • Any other cosmetic procedure at the surgical site, including laser or filler injection
  • Myasthenia gravis and other neuromuscular disorders

Investigators

Similar Trials